These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38365306)

  • 1. PI3K-AKT/mTOR Signaling in Psychiatric Disorders: A Valuable Target to Stimulate or Suppress?
    Chen Y; Guan W; Wang ML; Lin XY
    Int J Neuropsychopharmacol; 2024 Feb; 27(2):. PubMed ID: 38365306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13.
    Lu Y; Wang C; Xue Z; Li C; Zhang J; Zhao X; Liu A; Wang Q; Zhou W
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25542689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor.
    Zou CY; Smith KD; Zhu QS; Liu J; McCutcheon IE; Slopis JM; Meric-Bernstam F; Peng Z; Bornmann WG; Mills GB; Lazar AJ; Pollock RE; Lev D
    Mol Cancer Ther; 2009 May; 8(5):1157-68. PubMed ID: 19417153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrine Exerts Antidepressant-Like Effects on Mice: Role of the Hippocampal PI3K/Akt/mTOR Signaling.
    Wu Z; You Z; Chen P; Chen C; Chen F; Shen J; Xu H
    Int J Neuropsychopharmacol; 2018 Aug; 21(8):764-776. PubMed ID: 29668939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765.
    Neis VB; Moretti M; Rosa PB; Dalsenter YO; Werle I; Platt N; Kaufmann FN; Rosado AF; Besen MH; Rodrigues ALS
    Pharmacol Biochem Behav; 2020 Nov; 198():173020. PubMed ID: 32861641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of PI3K/Akt/GSK-3β and mTOR in the antidepressant-like effect of atorvastatin in mice.
    Ludka FK; Constantino LC; Dal-Cim T; Binder LB; Zomkowski A; Rodrigues AL; Tasca CI
    J Psychiatr Res; 2016 Nov; 82():50-7. PubMed ID: 27468164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.
    Martelli AM; Evangelisti C; Chiarini F; McCubrey JA
    Oncotarget; 2010 Jun; 1(2):89-103. PubMed ID: 20671809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside.
    Martelli AM; Tazzari PL; Evangelisti C; Chiarini F; Blalock WL; Billi AM; Manzoli L; McCubrey JA; Cocco L
    Curr Med Chem; 2007; 14(19):2009-23. PubMed ID: 17691943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural products attenuate PI3K/Akt/mTOR signaling pathway: A promising strategy in regulating neurodegeneration.
    Fakhri S; Iranpanah A; Gravandi MM; Moradi SZ; Ranjbari M; Majnooni MB; Echeverría J; Qi Y; Wang M; Liao P; Farzaei MH; Xiao J
    Phytomedicine; 2021 Oct; 91():153664. PubMed ID: 34391082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent studies on PI3K/AKT/mTOR signaling pathway in hematopoietic stem cells].
    Zhang YC; Cheng T; Yuan WP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):245-9. PubMed ID: 23484729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy dysfunction contributes to NLRP1 inflammasome-linked depressive-like behaviors in mice.
    Zhu YJ; Huang J; Chen R; Zhang Y; He X; Duan WX; Zou YL; Sun MM; Sun HL; Cheng SM; Wang HC; Zhang H; Wu WN
    J Neuroinflammation; 2024 Jan; 21(1):6. PubMed ID: 38178196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance.
    Ediriweera MK; Tennekoon KH; Samarakoon SR
    Semin Cancer Biol; 2019 Dec; 59():147-160. PubMed ID: 31128298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Abnormal PI3K/AKT/mTOR Signaling in Intracerebral Hemorrhage: A Systematic Review on Potential Drug Targets and Influences of Signaling Modulators on Other Neurological Disorders.
    Jadaun KS; Sharma A; Siddiqui EM; Mehan S
    Curr Rev Clin Exp Pharmacol; 2022; 17(3):174-191. PubMed ID: 34455956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer.
    Pungsrinont T; Kallenbach J; Baniahmad A
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting PI3K-AKT/mTOR signaling in the prevention of autism.
    Sharma A; Mehan S
    Neurochem Int; 2021 Jul; 147():105067. PubMed ID: 33992742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer.
    Mabuchi S; Kuroda H; Takahashi R; Sasano T
    Gynecol Oncol; 2015 Apr; 137(1):173-9. PubMed ID: 25677064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway.
    Ni RJ; Gao TH; Wang YY; Tian Y; Wei JX; Zhao LS; Ni PY; Ma XH; Li T
    Zool Res; 2022 Nov; 43(6):989-1004. PubMed ID: 36257830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS Promote Ox-LDL-Induced Platelet Activation by Up-Regulating Autophagy Through the Inhibition of the PI3K/AKT/mTOR Pathway.
    Wang X; Fu YF; Liu X; Feng G; Xiong D; Mu GF; Chen FP
    Cell Physiol Biochem; 2018; 50(5):1779-1793. PubMed ID: 30384368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of PI3K/Akt/mTOR signaling in dose-dependent biphasic effects of glycine on vascular development.
    Tsuji-Tamura K; Sato M; Fujita M; Tamura M
    Biochem Biophys Res Commun; 2020 Aug; 529(3):596-602. PubMed ID: 32736679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.